SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement

SINTX Technologies (NASDAQ: SINT) announced that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders’ equity of $2.5 million for companies listed on the Nasdaq Capital Market.

Rhea-AI Summary

SINTX Technologies (NASDAQ: SINT) announced that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders’ equity of $2.5 million for companies listed on the Nasdaq Capital Market. Nasdaq’s decision is based on SINTX’s Form 10-Q for the quarter ended June 30, 2026, which reported stockholders’ equity of approximately $4.83 million. Nasdaq confirmed that the previously disclosed stockholders’ equity deficiency matter is now closed. Management stated that resolving this listing issue supports SINTX’s efforts to strengthen the company while it focuses on commercializing its silicon nitride technologies, expanding its distribution network, and pursuing strategic partnerships aimed at supporting future revenue growth in its medical and advanced ceramics businesses.

Positive

• Regained Nasdaq equity compliance with $4.83 million stockholders’ equity vs. $2.5 million minimum
• Nasdaq deficiency matter closed, removing an overhang on listing status
• Clear focus on commercialization of silicon nitride products and distribution expansion

Negative

• Recent Nasdaq equity deficiency highlights prior balance sheet pressures despite current compliance

Argus Aug 13 session 12 alerts

+5.10% close to close 36.6x rel. volume Open Argus

Details

Market move: SINT +5.10% in the Aug 13 session. Nasdaq compliance resolution

+11.9% Peak in 4 hr 24 min

$13.15M Market Cap

On Aug 13, the day this news came out, SINT closed 5.10% above the previous close. Argus tracked a peak move of +11.9% during that session. Our momentum scanner recorded 12 alerts for this stock that day. Relative volume reached 36.6x the daily average during tracking.

Data tracked by StockTitan Argus for the Aug 13 session.

Market Context

On Aug 13, the day this news came out, the stock closed 5.1% above the previous close. The prior mid...

Analysis

On Aug 13, the day this news came out, the stock closed 5.1% above the previous close. The prior mid-year update preceded a -12.43% 24-hour reaction, providing a sourced contrast for this compliance resolution. The active S-3 is a resale registration, and low short positioning remains a separate risk.

Key Figures

Minimum stockholders’ equity: $2.5 million Stockholders’ equity: $4.83 million

Minimum stockholders’ equity

$2.5 million

Nasdaq Listing Rule 5550(b)(1) requirement

Stockholders’ equity

$4.83 million

Quarter ended June 30, 2026

Historical Context

5 past events · Latest: Aug 11

5 events

1. Aug 11

   Business update

   24h Move

   -12.4%

   Commercial execution update included purchase orders, revenue outlook and additional financing.

2. Jul 28

   Earnings release date

   24h Move

   +0.7%

   Company scheduled second-quarter results release and investor webcast for August 11.

3. Jul 23

   Strategic program

   24h Move

   -2.6%

   Southern Metrics engagement established a program to evaluate strategic corporate-development opportunities.

4. Jun 22

   Purchase orders

   24h Move

   -5.7%

   Multiple customers placed more than $3.2 million in advanced ceramics purchase orders.

5. Jun 03

   Private placement

   24h Move

   +7.7%

   Private placement and ATM sales generated approximately $5.0 million in equity capital.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

stockholders’ equity, silicon nitride, fda-cleared

3 terms

stockholders’ equity financial

"minimum stockholders’ equity of $2.5 million"

Stockholders’ equity is the portion of a company’s value that belongs to its owners after subtracting what the company owes from what it owns — like the equity in a house after paying the mortgage. For investors it shows the company’s net worth and can indicate financial strength, a cushion against losses, and the amount potentially available to support dividends or reinvestment; tracking changes helps assess whether the business is building or eroding owner value.

silicon nitride technical

"company focused on advanced silicon nitride materials"

A very hard, lightweight ceramic material made from silicon and nitrogen that resists heat, wear and corrosion. Think of it as industrial-grade pottery that can take extreme conditions where metals or plastics would fail. For investors, its use in high-performance bearings, engine parts, electronics and medical implants can signal exposure to premium, durable products, specialized manufacturing margins and markets with long-term replacement cycles.

fda-cleared regulatory

"FDA-cleared SINAPTIC Foot & Ankle Implant System"

FDA-cleared means a medical product—typically a device or diagnostic—has passed a U.S. regulator’s review showing it is substantially similar to an existing approved product and is safe and effective for its intended use. For investors, clearance acts like an official safety stamp that lowers regulatory risk and can speed market access, comparable to getting a trusted roadworthy certificate before selling cars, which can make sales and adoption happen faster.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a company focused on advanced silicon nitride materials and medical technologies, today announced that it received written notification from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain minimum stockholders’ equity of $2.5 million.

Based on SINTX’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which reported stockholders’ equity of approximately $4.83 million, Nasdaq determined that the Company complies with the minimum stockholders’ equity requirement under Listing Rule 5550(b)(1) and confirmed that the previously disclosed deficiency matter is now closed.

“We are pleased to have resolved this matter and to have Nasdaq confirm our compliance with the minimum stockholders’ equity requirement,” said Eric K. Olson, Chairman and Chief Executive Officer of SINTX Technologies. “This is an important step as we continue to strengthen the Company and focus our resources on the commercialization of our silicon nitride technologies and the execution of our growth strategy.”

The Company remains focused on advancing the commercialization of its silicon nitride-based medical products, expanding its distribution network and developing strategic partnerships designed to support future revenue growth.

About SINTX

Headquartered in Salt Lake City, Utah, SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. SINTX’s technologies are supported by peer-reviewed research, a patent portfolio, U.S.-based manufacturing capabilities and strategic industry relationships. The Company’s business includes proprietary biomaterials and medical device technologies, as well as contract manufacturing and other advanced ceramics opportunities. SINTX’s product portfolio includes the FDA-cleared SINAPTIC Foot & Ankle Implant System for reconstructive surgery.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s commercialization initiatives, expansion of its distribution network, development of strategic partnerships, growth strategy, future revenue growth and ability to maintain compliance with the continued listing requirements of The Nasdaq Stock Market. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include those described in the Company’s filings with the U.S. Securities and Exchange Commission, including under the heading “Risk Factors.” Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to update any forward-looking statement, except as required by applicable law.

SINTX Contacts:
Investor Relations
Gregg Honigblum, Chief Investment Officer
P: 801-839-3502
E: IR@sintx.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SINTX Technologies (NASDAQ: SINT) announce about Nasdaq compliance on August 13, 2026?

SINTX Technologies announced it has regained compliance with Nasdaq’s stockholders’ equity requirement. According to SINTX, Nasdaq confirmed the company now meets Listing Rule 5550(b)(1) and that the previously disclosed minimum equity deficiency matter related to its Nasdaq Capital Market listing is closed.

What is the minimum stockholders’ equity requirement for SINTX (SINT) to remain listed on Nasdaq?

The minimum stockholders’ equity requirement is $2.5 million under Nasdaq Listing Rule 5550(b)(1). According to SINTX, Nasdaq reviewed its June 30, 2026 Form 10-Q and determined the company currently exceeds this threshold for continued listing on the Nasdaq Capital Market.

How much stockholders’ equity did SINTX Technologies report as of June 30, 2026?

SINTX reported approximately $4.83 million in stockholders’ equity as of June 30, 2026. According to SINTX, this level of equity was sufficient for Nasdaq to determine that the company complies with Listing Rule 5550(b)(1) and to close the previously disclosed equity deficiency issue.

What does regaining Nasdaq compliance mean for SINTX (SINT) shareholders?

Regaining compliance means Nasdaq no longer views SINTX as deficient on minimum equity requirements. According to SINTX, closing this listing matter allows management to concentrate resources on commercializing silicon nitride technologies and executing its stated growth strategy across medical and advanced ceramics markets.

Is the previous Nasdaq stockholders’ equity deficiency issue for SINTX now resolved?

Yes, Nasdaq has confirmed the prior stockholders’ equity deficiency matter is closed. According to SINTX, the determination followed review of its June 30, 2026 Form 10-Q, which showed stockholders’ equity of about $4.83 million, exceeding the $2.5 million minimum requirement.

What strategic focus did SINTX Technologies outline after regaining Nasdaq compliance?

SINTX said it will focus on commercializing its silicon nitride-based medical products and expanding distribution. According to SINTX, the company is also developing strategic partnerships designed to support future revenue growth across its biomaterials, medical device, and contract manufacturing businesses.